Clinical trial
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE…
NCT00314145 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00314145 |
|---|---|
| Title | A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX |
| Official title | A Multicentre, Randomized, Double-blind, Phase III Study of The Comparative Immunogenicity, Safety and Tolerability of Two Japanese Encephalitis Vaccines (ChimeriVax™-JE and JE-VAX®) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Japanese Encephalitis |
| Intervention type | Biological |
| Interventions | ChimeriVax™-JE, JE-VAX® |
| Enrollment | 820 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 13, 2006 |
| Last update posted | Dec 6, 2012 |
| Countries | Australia, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: